Skip to content

Study to assess the role of rifaximin in glycaemic control of poorly controlled diabetics.

Randomized Controlled Trial to assess effect of an additional short course of rifaximin compared to standard therapy alone for glycaemic control among poorly controlled diabetics

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2018/004
Enrollment
Unknown
Registered
2018-01-25
Start date
2018-02-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Study setting: Professorial Medical Unit, North Colombo Teaching Hospital, Ragama. Participants will be requested to attend on an allocated day prior to lunch after due medications. They will be requ

Sponsors

Faculty of Medicine, University of Kelaniya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female patients aged between 18-80 years 2. Type 2 diabetes for more than 5 years with last HbA1c done within three months of recruitment of more than 8%

Exclusion criteria

Exclusion criteria: 1. Patients with known allergies to rifaximin. 2. Patients who have taken any antibiotic within three months prior to the recruitment. 3. Patients who are on continuous proton pump inhibitors for more than one month duration at the time of recruitment 4. Patients who are on concurrent vitamin supplements at the time of recruitment. 5. Patients who have chronic lower gastro intestinal symptoms at the time of recruitment. 6. Patients who are pregnant or lactating

Design outcomes

Primary

MeasureTime frame
Glycaemic control assessed by reduction in HbA1c value >1% and/or reduction in post-prandial blood glucose (PPBG) >10% from baseline [HbA1C: At baseline and at the end of three months after the commencement of the intervention PPBG: At baseline, and at the end of two weeks and four weeks after the commencement of the intervention]

Secondary

MeasureTime frame
None [None]

Countries

Sri Lanka

Contacts

Public ContactProf. B.A.H. Ranjan Premaratne

Professor in Medicine

ranjanp64@gmail.comTel: +94 11 2953409 / 11 2961119

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026